Standard
Adrenaline autoinjector is underprescribed in typical cold urticaria patients. / Bizjak, Mojca; Košnik, Mitja; Dinevski, Dejan; Thomsen, Simon Francis; Fomina, Daria; Borzova, Elena; Kulthanan, Kanokvalai; Meshkova, Raisa; Aarestrup, Fernando Monteiro; Ahsan, Dalia Melina; Al-Ahmad, Mona; Altrichter, Sabine; Bauer, Andrea; Brockstädt, Maxi; Costa, Célia; Demir, Semra; Criado, Roberta Fachini; Ensina, Luis Felipe; Gelincik, Asli; Giménez-Arnau, Ana Maria; Gonçalo, Margarida; Gotua, Maia; Holm, Jesper Grønlund; Inomata, Naoko; Kasperska-Zajac, Alicja; Khoshkhui, Maryam; Klyucharova, Aliya; Kocatürk, Emek; Lu, Rongbiao; Makris, Michael; Maltseva, Natalya; Pasali, Maria; Paulino, Marisa; Pesqué, David; Peter, Jonny; Ramón, German Dario; Ritchie, Carla; Rodrigues Valle, Solange Oliveira; Rudenko, Michael; Sikora, Agnieszka; Wagner, Nicola; Xepapadaki, Paraskevi; Xue, Xiaoyang; Zhao, Zuotao; Terhorst-Molawi, Dorothea; Maurer, Marcus.
I:
Allergy: European Journal of Allergy and Clinical Immunology, Bind 77, Nr. 7, 2022, s. 2224-2229.
Publikation: Bidrag til tidsskrift › Letter › Forskning › fagfællebedømt
Harvard
Bizjak, M, Košnik, M, Dinevski, D
, Thomsen, SF, Fomina, D, Borzova, E, Kulthanan, K, Meshkova, R, Aarestrup, FM, Ahsan, DM, Al-Ahmad, M, Altrichter, S, Bauer, A, Brockstädt, M, Costa, C, Demir, S, Criado, RF, Ensina, LF, Gelincik, A, Giménez-Arnau, AM, Gonçalo, M, Gotua, M, Holm, JG, Inomata, N, Kasperska-Zajac, A, Khoshkhui, M, Klyucharova, A, Kocatürk, E, Lu, R, Makris, M, Maltseva, N, Pasali, M, Paulino, M, Pesqué, D, Peter, J, Ramón, GD, Ritchie, C, Rodrigues Valle, SO, Rudenko, M, Sikora, A, Wagner, N, Xepapadaki, P, Xue, X, Zhao, Z, Terhorst-Molawi, D & Maurer, M 2022, '
Adrenaline autoinjector is underprescribed in typical cold urticaria patients',
Allergy: European Journal of Allergy and Clinical Immunology, bind 77, nr. 7, s. 2224-2229.
https://doi.org/10.1111/all.15274
APA
Bizjak, M., Košnik, M., Dinevski, D.
, Thomsen, S. F., Fomina, D., Borzova, E., Kulthanan, K., Meshkova, R., Aarestrup, F. M., Ahsan, D. M., Al-Ahmad, M., Altrichter, S., Bauer, A., Brockstädt, M., Costa, C., Demir, S., Criado, R. F., Ensina, L. F., Gelincik, A., ... Maurer, M. (2022).
Adrenaline autoinjector is underprescribed in typical cold urticaria patients.
Allergy: European Journal of Allergy and Clinical Immunology,
77(7), 2224-2229.
https://doi.org/10.1111/all.15274
Vancouver
Bizjak M, Košnik M, Dinevski D
, Thomsen SF, Fomina D, Borzova E o.a.
Adrenaline autoinjector is underprescribed in typical cold urticaria patients.
Allergy: European Journal of Allergy and Clinical Immunology. 2022;77(7):2224-2229.
https://doi.org/10.1111/all.15274
Author
Bizjak, Mojca ; Košnik, Mitja ; Dinevski, Dejan ; Thomsen, Simon Francis ; Fomina, Daria ; Borzova, Elena ; Kulthanan, Kanokvalai ; Meshkova, Raisa ; Aarestrup, Fernando Monteiro ; Ahsan, Dalia Melina ; Al-Ahmad, Mona ; Altrichter, Sabine ; Bauer, Andrea ; Brockstädt, Maxi ; Costa, Célia ; Demir, Semra ; Criado, Roberta Fachini ; Ensina, Luis Felipe ; Gelincik, Asli ; Giménez-Arnau, Ana Maria ; Gonçalo, Margarida ; Gotua, Maia ; Holm, Jesper Grønlund ; Inomata, Naoko ; Kasperska-Zajac, Alicja ; Khoshkhui, Maryam ; Klyucharova, Aliya ; Kocatürk, Emek ; Lu, Rongbiao ; Makris, Michael ; Maltseva, Natalya ; Pasali, Maria ; Paulino, Marisa ; Pesqué, David ; Peter, Jonny ; Ramón, German Dario ; Ritchie, Carla ; Rodrigues Valle, Solange Oliveira ; Rudenko, Michael ; Sikora, Agnieszka ; Wagner, Nicola ; Xepapadaki, Paraskevi ; Xue, Xiaoyang ; Zhao, Zuotao ; Terhorst-Molawi, Dorothea ; Maurer, Marcus. / Adrenaline autoinjector is underprescribed in typical cold urticaria patients. I: Allergy: European Journal of Allergy and Clinical Immunology. 2022 ; Bind 77, Nr. 7. s. 2224-2229.
Bibtex
@article{435484adcaeb45708f3497d980d8c45f,
title = "Adrenaline autoinjector is underprescribed in typical cold urticaria patients",
keywords = "adrenaline autoinjector, cold urticaria, COLD-CE, cold-induced anaphylaxis",
author = "Mojca Bizjak and Mitja Ko{\v s}nik and Dejan Dinevski and Thomsen, {Simon Francis} and Daria Fomina and Elena Borzova and Kanokvalai Kulthanan and Raisa Meshkova and Aarestrup, {Fernando Monteiro} and Ahsan, {Dalia Melina} and Mona Al-Ahmad and Sabine Altrichter and Andrea Bauer and Maxi Brockst{\"a}dt and C{\'e}lia Costa and Semra Demir and Criado, {Roberta Fachini} and Ensina, {Luis Felipe} and Asli Gelincik and Gim{\'e}nez-Arnau, {Ana Maria} and Margarida Gon{\c c}alo and Maia Gotua and Holm, {Jesper Gr{\o}nlund} and Naoko Inomata and Alicja Kasperska-Zajac and Maryam Khoshkhui and Aliya Klyucharova and Emek Kocat{\"u}rk and Rongbiao Lu and Michael Makris and Natalya Maltseva and Maria Pasali and Marisa Paulino and David Pesqu{\'e} and Jonny Peter and Ram{\'o}n, {German Dario} and Carla Ritchie and {Rodrigues Valle}, {Solange Oliveira} and Michael Rudenko and Agnieszka Sikora and Nicola Wagner and Paraskevi Xepapadaki and Xiaoyang Xue and Zuotao Zhao and Dorothea Terhorst-Molawi and Marcus Maurer",
note = "Funding Information: M. Bizjak has been a speaker and served on advisory boards for Novartis, outside the submitted work. S. F. Thomsen reports grants and non‐financial support from Novartis, Sanofi, UCB, LEO Pharma, and Janssen, outside the submitted work. D. Fomina received honoraria from Novartis, Shire, Behring CSL and Sanofi, outside the submitted work. E. Borzova received honoraria for educational lectures from Novartis and Sanofi and research funding from GSK, outside the submitted work. K. Kulthanan reports grants from Novartis and received honoraria from Menarini and Takeda, outside the submitted work. R. Meshkova received honoraria from Novartis, outside the submitted work. S. Altrichter reports grants and personal fees from Astra‐Zeneca, grants from Allakos, personal fees from Novartis, non‐financial support from Moxie, grants from CSL Behring, grants from LEO Pharma, outside the submitted work. A. Bauer reports grants, personal fees and other from Novartis, personal fees and other from LEO Pharma, grants, personal fees and other from Sanofi/Regeneron, other from Amgen, other from Lilly, other from AbbVie, personal fees from Takeda, other from Pharvaris, outside the submitted work. C. Costa reports personal fees from Novartis, AstraZeneca, Menarini, Leti and Bial, outside the submitted work. R. Fachini Criado reports personal fees from Novartis, Takeda, Abbvie and Sanofi, outside the submitted work. L.F. Felipe Ensina reports personal fees from Novartis, Sanofi, Abbvie and Takeda, outside the submitted work. A.M. Gim{\'e}nez‐Arnau reports grants and personal fees from Uriach, other from Genentech, grants, personal fees and other from Novartis, grants and personal fees from GSK, personal fees from Sanofi/Regeneron, personal fees from Amgen, personal fees from Thermo Fisher, grants from Instituto Carlos III, personal fees from LEO Pharma, personal fees from Almirall and personal fees from Avene, outside the submitted work. M. Gon{\c c}alo has been a speaker and/or advisor for Abbie, LEO Phama, Lilly, Novartis, Pfizer, Sanofi and Takeda, outside the submitted work. J.G. Holm has been a speaker for Novartis, outside the submitted work. E. Kocat{\"u}rk reports personal fees from Novartis, Sanofi and Menarini, outside the submitted work. M. Makris reports personal fees from Novartis, Chiesi Hellas, AstraZeneca, Pfizer, GSK and Menarini, outside the submitted work. S. Valle reports personal fees from Novartis, Takeda, CSL Behring and Astra‐Zeneca outside the submitted work. N. Wagner is or recently was a speaker and/or advisor for and/or has received research funding or is/was involved in clinical trials of/from ALK‐Abell{\'o}, Novartis Pharma GmbH, Allergopharma GmbH &Co KG, Sanofi‐Aventis Deutschland GmbH, Shire/Takeda, Blueprint, Abbvie GmbH & Co KG. P. Xepapadaki reports personal fees from Uriach, Novartis, Nestle and Nutricia, outside the submitted work. M. Mauer is or recently was a speaker and/or advisor for and/or has received research funding from Allakos, Aralez, ArgenX, AstraZeneca, Celldex, Centogene, CSL Behring, FAES, Genentech, GIInnovation, Innate Pharma, Kyowa Kirin, LEO Pharma, Lilly, Menarini, Moxie, MSD, Novartis, Roche, Sanofi/Regeneron, Third HarmonicBio, UCB, and Uriach, outside the submitted work. All other authors have no conflict of interest within the scope of the submitted work. ",
year = "2022",
doi = "10.1111/all.15274",
language = "English",
volume = "77",
pages = "2224--2229",
journal = "Allergy: European Journal of Allergy and Clinical Immunology",
issn = "0105-4538",
publisher = "Wiley Online",
number = "7",
}
RIS
TY - JOUR
T1 - Adrenaline autoinjector is underprescribed in typical cold urticaria patients
AU - Bizjak, Mojca
AU - Košnik, Mitja
AU - Dinevski, Dejan
AU - Thomsen, Simon Francis
AU - Fomina, Daria
AU - Borzova, Elena
AU - Kulthanan, Kanokvalai
AU - Meshkova, Raisa
AU - Aarestrup, Fernando Monteiro
AU - Ahsan, Dalia Melina
AU - Al-Ahmad, Mona
AU - Altrichter, Sabine
AU - Bauer, Andrea
AU - Brockstädt, Maxi
AU - Costa, Célia
AU - Demir, Semra
AU - Criado, Roberta Fachini
AU - Ensina, Luis Felipe
AU - Gelincik, Asli
AU - Giménez-Arnau, Ana Maria
AU - Gonçalo, Margarida
AU - Gotua, Maia
AU - Holm, Jesper Grønlund
AU - Inomata, Naoko
AU - Kasperska-Zajac, Alicja
AU - Khoshkhui, Maryam
AU - Klyucharova, Aliya
AU - Kocatürk, Emek
AU - Lu, Rongbiao
AU - Makris, Michael
AU - Maltseva, Natalya
AU - Pasali, Maria
AU - Paulino, Marisa
AU - Pesqué, David
AU - Peter, Jonny
AU - Ramón, German Dario
AU - Ritchie, Carla
AU - Rodrigues Valle, Solange Oliveira
AU - Rudenko, Michael
AU - Sikora, Agnieszka
AU - Wagner, Nicola
AU - Xepapadaki, Paraskevi
AU - Xue, Xiaoyang
AU - Zhao, Zuotao
AU - Terhorst-Molawi, Dorothea
AU - Maurer, Marcus
N1 - Funding Information:
M. Bizjak has been a speaker and served on advisory boards for Novartis, outside the submitted work. S. F. Thomsen reports grants and non‐financial support from Novartis, Sanofi, UCB, LEO Pharma, and Janssen, outside the submitted work. D. Fomina received honoraria from Novartis, Shire, Behring CSL and Sanofi, outside the submitted work. E. Borzova received honoraria for educational lectures from Novartis and Sanofi and research funding from GSK, outside the submitted work. K. Kulthanan reports grants from Novartis and received honoraria from Menarini and Takeda, outside the submitted work. R. Meshkova received honoraria from Novartis, outside the submitted work. S. Altrichter reports grants and personal fees from Astra‐Zeneca, grants from Allakos, personal fees from Novartis, non‐financial support from Moxie, grants from CSL Behring, grants from LEO Pharma, outside the submitted work. A. Bauer reports grants, personal fees and other from Novartis, personal fees and other from LEO Pharma, grants, personal fees and other from Sanofi/Regeneron, other from Amgen, other from Lilly, other from AbbVie, personal fees from Takeda, other from Pharvaris, outside the submitted work. C. Costa reports personal fees from Novartis, AstraZeneca, Menarini, Leti and Bial, outside the submitted work. R. Fachini Criado reports personal fees from Novartis, Takeda, Abbvie and Sanofi, outside the submitted work. L.F. Felipe Ensina reports personal fees from Novartis, Sanofi, Abbvie and Takeda, outside the submitted work. A.M. Giménez‐Arnau reports grants and personal fees from Uriach, other from Genentech, grants, personal fees and other from Novartis, grants and personal fees from GSK, personal fees from Sanofi/Regeneron, personal fees from Amgen, personal fees from Thermo Fisher, grants from Instituto Carlos III, personal fees from LEO Pharma, personal fees from Almirall and personal fees from Avene, outside the submitted work. M. Gonçalo has been a speaker and/or advisor for Abbie, LEO Phama, Lilly, Novartis, Pfizer, Sanofi and Takeda, outside the submitted work. J.G. Holm has been a speaker for Novartis, outside the submitted work. E. Kocatürk reports personal fees from Novartis, Sanofi and Menarini, outside the submitted work. M. Makris reports personal fees from Novartis, Chiesi Hellas, AstraZeneca, Pfizer, GSK and Menarini, outside the submitted work. S. Valle reports personal fees from Novartis, Takeda, CSL Behring and Astra‐Zeneca outside the submitted work. N. Wagner is or recently was a speaker and/or advisor for and/or has received research funding or is/was involved in clinical trials of/from ALK‐Abelló, Novartis Pharma GmbH, Allergopharma GmbH &Co KG, Sanofi‐Aventis Deutschland GmbH, Shire/Takeda, Blueprint, Abbvie GmbH & Co KG. P. Xepapadaki reports personal fees from Uriach, Novartis, Nestle and Nutricia, outside the submitted work. M. Mauer is or recently was a speaker and/or advisor for and/or has received research funding from Allakos, Aralez, ArgenX, AstraZeneca, Celldex, Centogene, CSL Behring, FAES, Genentech, GIInnovation, Innate Pharma, Kyowa Kirin, LEO Pharma, Lilly, Menarini, Moxie, MSD, Novartis, Roche, Sanofi/Regeneron, Third HarmonicBio, UCB, and Uriach, outside the submitted work. All other authors have no conflict of interest within the scope of the submitted work.
PY - 2022
Y1 - 2022
KW - adrenaline autoinjector
KW - cold urticaria
KW - COLD-CE
KW - cold-induced anaphylaxis
U2 - 10.1111/all.15274
DO - 10.1111/all.15274
M3 - Letter
C2 - 35258111
AN - SCOPUS:85126263525
VL - 77
SP - 2224
EP - 2229
JO - Allergy: European Journal of Allergy and Clinical Immunology
JF - Allergy: European Journal of Allergy and Clinical Immunology
SN - 0105-4538
IS - 7
ER -